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( 57 ) ABSTRACT 
Systems and methods are provided for the removal of 
endotoxins from fluids . The methods can include the use of 
polymeric nanoparticles for binding endotoxins present in a 
fluid . The polymeric nanoparticles can be associated with a 
support member . The polymeric nanoparticles can have an 
endotoxin removal capacity of at least 1x10° endotoxin units 
per gram of polymeric nanoparticle ( EU / g ) and / or a removal 
efficacy per unit surface area of the polymeric nanoparticles 
of at least 1x10° EU / cm² . 
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SYSTEMS AND METHODS FOR Poly ( e - caprolactone ) ( PCL ) . Each of the polymeric nano 
ENDOTOXIN REMOVAL FROM FLUIDS particles has a maximum dimension of about 300 nm to 
about 500 nm , and the polymeric nanoparticles have an 
CROSS - REFERENCE TO RELATED endotoxin removal capacity of at least about 1x10° endo 
APPLICATIONS 5 toxin units per gram of polymeric nanoparticle ( EU / g ) and 
an endotoxin removal efficacy of at least 1x10° endotoxin 
This application claims priority to U . S . Provisional Appli - units per cm ? of nanoparticle surface area ( EU / cm² ) . 
cation Ser . No . 62 / 178 , 647 entitled “ POLYMERIC NANO 
PARTICLES FOR DRUG DELIVERY AND BACTERIAL BRIEF DESCRIPTION OF THE SEVERAL 
TOXIN REMOVAL , ” filed Apr . 15 , 2015 , the disclosure of 10 VIEWS OF THE DRAWINGS 
which is hereby incorporated by reference as if set forth in 
its entirety herein . The present invention is described in detail below with 
reference to the attached drawing figures , wherein : 
FIELD FIG . 1 is a schematic depiction of an exemplary phase 
separation system for making polymeric nanoparticles , Systems and methods are provided for the removal of according to an aspect of the invention ; 
endotoxins from fluids . FIG . 2 is a schematic depiction of an endotoxin removal 
BACKGROUND system , according to an aspect of the invention ; 20 FIG . 3 is a schematic depiction of another endotoxin 
Antigenic responses to gram - negative bacterial infec removal system , according to an aspect of the invention ; 
tions , gram - positive bacterial infections , fungal infections . FIG . 4 is a transmission electron microscopy image of a 
and / or parasite infections in human beings can be stimulated sample of polymeric nanoparticles as described in Example 
by endotoxins released from bacterial or other cell mem - 2 , according to an aspect of the invention ; 
branes when the cell membranes are ruptured through pro - 25 FIG . 5A is a graph of the size distribution by intensity for 
cesses such as enzymatic reactions . The release of such a sample of polymeric nanoparticles as measured by 
endotoxins may trigger sepsis or septic shock in patients , dynamic light scattering as described in Example 2 , accord 
which can lead to organ failure and / or death . ing to an aspect of the invention ; 
FIG . 5B is a graph of the zeta potential distribution for a SUMMARY 30 sample of polymeric nanoparticles as measured by dynamic 
light scattering as described in Example 2 , according to an In one aspect , an endotoxin removal system is provided . aspect of the invention ; The endotoxin removal system includes a plurality of poly FIG . 6 is a graph of the florescence intensity of BODIPY 
meric nanoparticles . Each polymeric nanoparticle of the Cadaverine ( BC ) as a function of endotoxin concentration as plurality of polymeric nanoparticles has a maximum dimen - 35 described in Example 3 , according to an aspect of the 
sion between 300 nm and 500 nm . The endotoxin removal invention ; system also includes a support member associated with the 
plurality of polymeric nanoparticles , where , when an aque FIG . 7 is a graph showing the percent endotoxin removal 
ous solution including endotoxin molecules is exposed to the as a function of the concentration of polymeric nanoparticles 
endotoxin removal system , the support member and the 40 as or and the 40 as described in Example 3 , according to an aspect of the 
plurality of polymeric nanoparticles are cooperatively con invention ; 
figured to separate at least a portion of the endotoxin FIGS . 8A and 8B are transmission electron microscopy 
molecules from the aqueous solution . Each polymeric nano - images showing endotoxins bound to the polymeric nano 
particle of the plurality of polymeric nanoparticles has an particles as described in Example 5 , according to an aspect 
endotoxin removal capacity of at least 1x10° endotoxin units 45 of the invention ; 
per gram of polymeric nanoparticle ( EU / g ) . FIG . 9A is graph of a zeta potential distribution measure 
In another aspect , a method for removing endotoxins from ment for an endotoxin sample as described in Example 5 , 
an aqueous solution is provided . The method includes according to an aspect of the invention ; 
exposing an aqueous solution including endotoxin mol - FIG . 9B is a graph of a zeta potential distribution mea 
ecules to polymeric nanoparticles so that at least a portion of 50 surement for the endotoxin sample in FIG . 9A compared to 
the endotoxin molecules bind to an exterior surface of one a zeta potential distribution measurement for the endotoxin 
or more of the polymeric nanoparticles to form endotoxin sample after binding to a predetermined concentration of bound polymeric nanoparticles . Each of the polymeric nano polymeric nanoparticles as described in Example 5 , accord particles has a maximum dimension of about 300 nm to ing to an aspect of the invention ; about 500 nm . Each of the polymeric nanoparticles have an 55 FIG . 10A is a graph showing the fluorescence intensity of endotoxin removal capacity of at least 1x10 endotoxin units BODIPY as a function of endotoxin concentration , accord per gram of polymeric nanoparticle ( EU / g ) . The method also ing to an aspect of the invention ; includes removing at least a portion of the aqueous solution 
from the endotoxin - bound polymeric nanoparticles . FIG . 10B is a graph showing the fluorescence intensity of 
In yet another aspect , a method for removing endotoxins 60 € 60 BODIPY as a function of 1 , 4 C - 1 , 4 bis polymer concentra 
from an aqueous solution is provided . The method includes tion , according to an aspect of the invention ; 
exposing an aqueous solution including endotoxin mol - FIG . 10C is a graph showing the fluorescence intensity of 
ecules to polymeric nanoparticles so that at least a portion of BODIPY as a function of EGDE - 3 , 3 ' polymer concentration , 
the endotoxin molecules bind to an outer surface of one or according to an aspect of the invention ; 
more of the polymeric nanoparticles to form endotoxin - 65 FIG . 10D is a graph showing the fluorescence intensity of 
bound polymeric nanoparticles , where at least the outer B ODIPY as a function of PCL nanoparticle concentration , 
surface of each of the polymeric nanoparticles includes according to an aspect of the invention ; and 
US 9 , 918 , 943 B2 
FIG . 10E is a graph showing the fluorescence intensity of The endotoxin removal system and methods disclosed 
BODIPY as a function of polyethyleneimine polymer con - herein solve one or more of the above problems . The 
centration , according to an aspect of the invention . methods and systems described herein have shown to be 
much more efficient than the known methods for endotoxin 
DETAILED DESCRIPTION 5 removal . For example , the methods and systems disclosed 
herein include the synthesis and use of polymeric nanopar 
In various aspects , an endotoxin removal system and ticles to efficiently sequester and / or bind endotoxins from 
methods for removing endotoxins from various fluids are contaminated fluids . In certain aspects , the polymeric nano 
disclosed . In certain aspects , the endotoxin removal system particles can have an endotoxin removal capacity of at least 
can include polymeric nanoparticles capable of binding to 10 about 1x10° endotoxin units per gram of polymeric nano 
endotoxins present in an aqueous solution . In one or more particle ( EU / g ) , which is several orders of magnitude higher 
aspects , the polymeric nanoparticles can be associated with than that of current commercially available endotoxin 
a support member , such as a film or beads , which can be removal systems , such a porous silica gel matrix . As used 
used together to filter an aqueous solution and remove is herein , endotoxin units ( EU ) refers to 0 . 1 to 0 . 2 nanograms 
endotoxin present in the solution . of endotoxin per mL . In the same or alternative aspects , the 
The control of microbial infections is important for the polymeric nanoparticles can exhibit an endotoxin removal 
preparation of biological media including water , in order to efficacy of at least 1x106 EU per unit surface area ( cm² ) of 
prevent or reduce the number of deaths claimed by septic the polymeric nanoparticles , which is about an order of 
shock or sepsis . This is particularly important because sepsis 20 magnitude higher than commercially available hydrophobic 
is one of the leading causes of death around the world with charged microporous membranes . 
an incidence estimated to be 18 million cases per year with In one or more aspects , the polymeric nanoparticles 
0 . 75 million cases in the U . S . alone , with this number being disclosed herein can bind to endotoxins from various types 
higher in areas where clean water sources are not readily of bacteria , such as Gram - negative and / or Gram - positive 
available . Additionally , sepsis is a common occurrence in 25 bacteria . In one aspect , the polymeric nanoparticles can bind 
clinical and hospital settings and more than half a million to an endotoxin from one or more Gram - negative bacterial 
patients are affected every year . Sepsis can be caused by both species . In such aspects , the one or more Gram - negative 
Gram - positive and Gram - negative bacteria and some of the bacterial species includes E . coli . more common organisms responsible include , for example : In various aspects , the polymeric nanoparticles can 
Escherichia coli ( E . coli ) , Pseudomonas aeruginosa , 30 inc include one or more polymers . In certain aspects , the poly Chlamidya , Staphyloccocus , Listeria , and Streptococcus . mer can be any polymer that includes an aliphatic region or The bacterial cell membranes of these microorganisms can moiety that can hydrophobically interact with one or more release negatively or positively charged endotoxins , respec 
tively , depending on whether they are Gram - negative or endotoxins to bind the endotoxin ( s ) to the polymeric nano 
Gram - positive bacteria , when damaged . When the bacterial 35 par 35 particle . In the same or alternative aspects , the polymer can 
cell membranes are damaged by , for example , enzymatic be a polymer that includes an ionic region or moiety that can 
reactions , the endotoxins released , may cause a host of el electrostatically interact with one or more endotoxins to bind 
antigenic and inflammatory responses , in for example , a the endotoxin ( s ) to the polymeric nanoparticle . In one 
human body . aspect , the polymer can include both ionic and aliphatic 
One way to prevent bacterial infections is by removing 40 regions that are configured to interact with one or more 
the bacteria from the different sources , such as water . endotoxins via electrostatic interactions and via hydropho 
Various methods including distillation , ethylene oxide treat - bic interactions to bind the endotoxin ( s ) to the polymeric 
ment , filtration , and irradiation have been employed to nanoparticle . 
remove endotoxins from contaminated fluids , some methods A non - limiting list of exemplary polymers that can be 
being more efficient than others . These methods are mainly 45 included in the polymeric nanoparticles includes polyesters , 
based on adsorption , filtration , ionic interactions , and phase such as Poly ( e - caprolactone ) ( PCL ) , polylactic acid ( PLA ) , 
separation techniques . However , these methods have poor Poly ( lactic - co - glycolic acid ( PLGA ) , hyaluronic acid ( HA ) , 
selectivity and a low endotoxin binding ability , therefore , the poly ( acrylic acid ) ( PAA ) , poloxamers , polyethylene oxide 
overall efficiency of endotoxin removal of these methods ( PEO ) , polyethylene glycol ( PEG ) , and polyflutamic acid . In 
remains low . In other words , these methods are not efficient 50 certain aspects , the polymer can be biodegradable . By using 
in decreasing the endotoxin levels in a fluid to lower than a biodegradable or a biocompatible polymer , environmental 
0 . 05 ng / ml ( 0 . 5 endotoxin units / ml ) , which is the safest benefits can be provided in addition to a significant reduc 
exposure level to endotoxins , as determined by the U . S . tion of undesired bacterial toxicity , via endotoxin removal 
Food and Drug Administration . from a fluid . Such considerations are of great importance for 
Polylysine immobilized cellulose porous microspheres 55 both water purification and treatment of other types of 
have been used to remove endotoxins from protein solu - biological media or components that suffer from microbial 
tions . In this method , proteins elute quickly due to their large contaminations . 
size , while endotoxins diffuse into the particle pores and are In certain aspects , when the polymeric nanoparticles 
retained inside the microspheres . However , the adsorption comprises a polyester , the polyester can be characterized as 
kinetics of these microspheres is slow making it a time 60 an aliphatic polyester . An aliphatic polyester as used herein 
consuming process to achieve a safe endotoxin concentra - refers to a polyester having an aliphatic region that is 
tion level of 0 . 05 ng / ml . Additionally , these microspheres capable of engaging in hydrophobic interactions with 
are highly polydisperse , making it difficult to have a pre - another molecule , such as an endotoxin . 
dictable efficiency when used repetitively . Other endotoxin In one or more aspects , the polymeric nanoparticles can 
removal methods suffer from a low elute volume , poor 65 comprise , consist essentially of , or consist of one or more 
selectivity , poor efficiency , filtration fouling , and / or are biodegradable polymers . In certain aspects , the polymeric 
economically unviable . nanoparticles can comprise , consist essentially of , or consist 
US 9 , 918 , 943 B2 
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m 
of one or more polyesters . In one aspect , the polymeric removed by the polymeric nanoparticles based on the 
nanoparticles can comprise , consist essentially of , or consist change in fluorescence intensity levels of the samples 
of PCL . described above . 
In various aspects , the outer surface of the polymeric 
nanoparticles can comprise , consist essentially of , or consist 5 
of : one or more biodegradable polymers . In certain aspects , % endotoxin removal = ( Eq . 1 ) 
the outer surface of the polymeric nanoparticles can com BC plus endotoxin plus NPs – prise , consist essentially of , or consist of one or more BC plus endotoxin polyesters . In one aspect , the outer surface of the polymeric 100 x = FI of ( BC plus NPs – BC alone ) 
nanoparticles can comprise , consist essentially of , or consist 
of PCL . 
In certain aspects , the polymeric nanoparticles can have a In certain aspects , the polymeric nanoparticles can have 
maximum dimension of at least about 200 nm , at least about an endotoxin removal efficacy per unit surface area of the 
250 nm , or at least about 300 nm ; about 700 nm or less , polymeric nanoparticle ( s ) of at least about 3x10 endotoxin 
about 600 nm or less , or about 500 nm or less ; or about 200 units per cm ? of the outer surface area of the polymeric 
nm to about 700 nm , about 200 nm to about 600 nm , about nanoparticles ( EU / cm² ) , or at least about 1x10° EU / cm² , or about 1 . 49x10° EU / cm² . The endotoxin removal efficacy per 200 nm to about 500 nm , about 250 nm to about 700 nm , unit surface area of the polymeric nanoparticle ( s ) can be about 250 nm to about 600 nm , about 250 nm to about 500 calculated using the fluorescence displacement assay 
nm , about 300 nm to about 700 nm , about 300 nm to about 20 O nm to about 20 described above . 600 nm , or about 300 nm to about 500 nm . As used herein , In calculating the endotoxin removal efficacy per unit 
maximum dimension refers to the maximum dimension of a outer surface area of the polymeric nanoparticle , the number 
nanoparticle , which can include a maximum diameter , maxi of nanoparticles is first calculated according to Equation 2 
mum length , maximum width , or maximum depth . For below : 
example , for a spherical polymeric nanoparticle , the maxi - 25 
mum dimension would refer to the maximum diameter . In 
another example , for a rod - shaped polymeric nanoparticle , ( 6 W X1012 ) ( Eq . 2 ) 
the maximum dimension refers the largest of the length , Number of polymer nanoparticles per ml = PXAX 3 
width , and depth of the rod - shaped nanoparticle . 
In certain aspects , the polymeric nanoparticles can have a 30 
substantially uniform size . In alternative aspects , the poly where , W is the concentration of polymeric nanoparticles in 
meric nanoparticles can have different sizes . In various g / ml , p is the density of polymeric nanoparticles in g / ml , and w is the diameter of the polymeric particles in um . It should aspects , the polymeric nanoparticles can have a polydisper be understood that these values can be determined by one 
sity index value of about 0 . 05 , 0 . 1 , 0 . 2 , 0 . 3 , or 0 . 4 . 35 skilled in the art using conventional techniques . For In various aspects , the polymeric nanoparticles can be any example , the diameter of the particles or the average diam shape or mixture of shapes . A non - limiting list of nanopar eter of the particles can be determined using transmission ticle shapes includes sphere - shaped , rod - shaped , and disk electron microscopy ( TEM ) , and / or Dynamic Light Scatter 
shaped . In certain aspects , the polymeric nanoparticles can ing ( DLS ) . The number of endotoxin units ( EU ) per unit 
be substantially one shape , such as approximately spherical . 40 outer surface area of the polymeric nanoparticles can be 
In one or more aspects , the polymeric nanoparticles can calculated according to the following equation ( 3 ) : 
remove at least about 60 % of an endotoxin present in an 
endotoxin - containing aqueous solution , at least about 65 % , 
at least about 70 % , or at least about 75 % . The % endotoxin ( Eq . 3 ) 
removal can be determined using any conventional molecu - 45 EU per unit outer surface area of polymeric nanoparticles = lar techniques known to one skilled in the art . An exemplary 
method for measuring the % endotoxin removal can include Total endotoxin removal by 
the use of a fluorescent displacement assay , such as a nanoparticles per ml of test solution 
BODIPY - Cadaverine ( BC ) - based fluorescence assay using ( surface area of each nanoparticle ) 
E . coli 055 : B5 endotoxin . As used herein BODIPY refers to 50 ( number of polymeric nanoparticles per ml )boron - dipyrromethene and is a commercially available fluo 
rescence dye , for example , available at Sigma . In this assay , 
the fluorescence intensity may be measured for given con In various aspects , the polymeric nanoparticles can have 
centrations of BC and the 055 : B5 endotoxin , or other an endotoxin removal capacity of at least about 1 . 5x107 
endotoxins , in a particular sample prior to endotoxin 55 endotoxin units per gram of polymeric nanoparticle ( EU / g ) , 
removal and after endotoxin removal from the particular at least about 1x108 EU / g , at least about 1x109 EU / g , or at 
sample . As endotoxins became bound to the surfaces of the least about 7x10° EU / g , or about 7 . 9x10° EU / g . The endo 
polymeric nanoparticles , the endotoxins release BC causing toxin removal capacity can be determined by dividing total 
an increase in the fluorescence intensity of BC . The change endotoxin removal by nanoparticles per ml of test solution 
in fluorescence intensity of BC can be determined using a 60 by the nanoparticle concentration in g / mL . 
commercially available plate reader ( Biotek ) . To determine In one or more aspects , the polymeric nanoparticles can 
the level of endotoxin removal by the polymeric nanopar - be synthesized in any manner known to one skilled in the art . 
ticles , the background fluorescence intensities of BC and In certain aspects , the polymeric nanoparticles can be syn 
polymeric nanoparticle control ( NPs ) , BC and endotoxin thesized using a one - step phase separation technique . Gen 
control , BC alone were subtracted to avoid any interfer - 65 erally , in such aspects , a solution of one or more polymers 
ences . The endotoxin removal efficiency were determined by in an organic phase can be precipitated out into an aqueous 
Eq . 1 , which calculates the amount ( % ) of endotoxin phase . 
US 9 , 918 , 943 B2 
In various aspects , the phase separation technique can various fluids , such as aqueous solutions . In various aspects , 
include injecting a solution of one or more polymers in an the versatility of the polymeric nanoparticles may be 
organic solvent , such as toluene , into an aqueous solution . In enhanced when the polymeric nanoparticles are associated 
certain aspects , the aqueous solution can include additives , with one or more types of support members , such as a film , 
such as surfactants , e . g . , polyvinyl alcohol . It is appreciated 5 membrane , or beads . In such aspects , the support member 
that one skilled in the art understands that the concentration may enhance the binding of endotoxin to the polymeric 
of polymer ( s ) in the organic solvent , the injection rate of the nanoparticles through non - specific binding of the endotoxin polymers into the aqueous solution , and / or the particular to the support member material , which can increase the local components of the aqueous solution can be modified to concentration of the endotoxin allowing for increased bind achieve specific sized and shaped nanoparticles . ing to the polymeric nanoparticles . In the same or alternative In certain aspects , the concentration of polymer in the 
organic solvent can range from about 0 . 1 mg / mL to about aspects , the support member may provide an efficient endo 
1000 mg /mL , or from about 1 mg / mL to about 100 , or can toxin separation mechanism by immobilizing the polymeric 
nanoparticles so an endotoxin - free fluid or reduced - endo be at least about 0 . 1 mg / mL , or at least about 1 mg / mL . In 
certain aspects , the concentration of polymer in the organic 15 toxin fluid can flow through or past the immobilized poly 
solvent can be about 10 mg / mL . meric nanoparticles bound with endotoxin . 
In one or more aspects , the flow rate or injection rate of An exemplary support member may include a film or 
the organic solvent comprising one or more polymers into membrane . Commercially available films or membranes are 
the aqueous phase can range from about 0 - 1000 uL / sec . suitable for use with the polymeric nanoparticles , such as 
Without being bound to any particular theory , when using 20 cellulose films , or various types of filter paper . In such 
the phase separation technique to make the polymeric nano - aspects , the polymeric nanoparticles may be embedded in 
particles , it is believed that the polymeric nanoparticles can the film or membrane and / or can be affixed to at least one 
be formed by phase separation at the boundary where the exterior surface of the film or membrane . 
organic solvent slowly diffuses into the aqueous solution . In one exemplary aspect , a cellulose based nanoparticle 
Further , without being bound to any particular theory , it is 25 film can be prepared by : 1 ) preparing a 50 : 50 solution of 
believed that the polymeric nanoparticles can form by virtue ethanol and isobutanol ; 2 ) preparing a 20 % NaOH - deion 
of van der Waals attractive forces between the individual ized water solution ; 3 ) weighing 20 g of alpha cellulose 
polymer molecules under low shear stress . Stated differently , powder ; 4 ) adding 200 ml ethanol - isobutanol solution ; 5 ) 
without being bound by any particular theory , as polymer mixing the cellulose mixture with stir bar at 900 rpm until 
molecules start precipitating out of an organic phase into an 30 well - mixed ( approx . 10 minutes ) ; 6 ) adding NaOH solution 
aqueous phase , the molecules can accumulate and form drop by drop until pH reaches 9 . 0 ; 7 ) setting the solution in 
spheres or other shapes under slow stirring conditions . oven until temperature is 60° C . ; 8 ) setting the stir bar to 900 
FIG . 1 depicts an exemplary system 100 that can be rpm for 30 minutes in oven ; 9 ) adding sodium chloroacetic 
utilized to synthesize polymeric nanoparticles using a phase acid drop by drop until the pH reaches 7 . 0 ; 10 ) neutralizing 
separation technique . The system 100 can include a syringe 35 and purify CMC solution with 20 ml of 96 % ethanol ; 11 ) 
pump 102 for injecting one or more polymer - containing adding polymeric nanoparticles ; 12 ) pouring the liquid 
solutions into an aqueous solution 106 housed in a vessel through 40 um strainer onto an aluminum plate ; 13 ) spread 
108 . A homogenizer 110 can also be positioned inside the the liquid evenly on plate ; and 14 ) let sit over - night . It is 
vessel 108 . It is appreciated that the components of this appreciated that one or more alterations can be made to such 
system 100 are commercially available and well known to 40 a nanoparticle film preparation . 
one skilled in the art . FIG . 2 depicts one exemplary filtering system 200 having 
In certain aspects , polymeric nanoparticles may be made a film or membrane 202 embedded with polymeric nano 
by injecting an organic solvent having a predetermined particles . FIG . 2 also depicts a fluid 204 containing endo 
concentration of polymer therein into an aqueous solution toxin being exposed to the membrane 202 . In the system 
using a syringe pump , such as the syringe pump 102 of the 45 200 , the polymeric nanoparticles can bind to the endotoxin 
system 100 of FIG . 1 . In one aspect , the concentration of the present in the fluid 204 . Since the polymeric nanoparticles 
polymer can be 10 mg / mL , the polymer can include PCL , are immobilized on the membrane 202 , the remainder of the 
and the organic solvent can include toluene . Further , in such fluid can pass through the membrane 202 thereby forming an 
an aspect , the aqueous solution can include about 1 % w / w endotoxin - free or reduced endotoxin fluid 206 . 
polyvinyl alcohol . To form the polymeric nanoparticles , the 50 In alternative aspects , the polymeric nanoparticles may be 
organic solvent and polymer solution can be delivered into immobilized on the outer surface of beads , such as beads 
the aqueous solution at a predetermined rate with constant comprising silica , silicon , cellulose , or a mixture thereof . It 
stirring and / or homogenizing , e . g . , using the homogenizer is appreciated that one skilled in the art would understand 
110 . In various aspects , the polymer dispersion may be how to immobilize the polymeric nanoparticles on the outer 
homogenized using the homogenizer 110 at about 300 rpm 55 surface of the beads using conventional techniques . In one 
for a predetermined period of time . The polymer dispersion exemplary aspect , the polymeric nanoparticles maybe cova 
may be stirred continuously for an extended period of time lently attached via a functional group present in the polymer , 
to remove any residual organic solvent by evaporation . After e . g . , an ester or amine group . 
the residual organic solvent is removed by evaporation , the In various aspects , both the beads and the polymeric 
polymeric nanoparticles may then be separated from the 60 nanoparticles may be considered non - porous , such that an 
aqueous phase by centrifugation , repeating this step as endotoxin - containing fluid does not enter the beads or 
necessary with added water , for washing the polymeric polymeric nanoparticles in order to remove endotoxin from 
nanoparticles from any residual organic solvents . Then , the the fluid . This is unlike , for example , other various filtering 
polymeric nanoparticles may be lyophilized , weighed , and techniques , where the endotoxin - containing fluid may enter 
stored at a temperature of about 4° C . 65 pores or channels in a particle , and where the endotoxin gets 
As discussed above , in certain aspects , the polymeric trapped and an endotoxin free fluid flows out of the pores or 
nanoparticles can be utilized to remove endotoxins from channels resulting in an endotoxin - free fluid . 
5 
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In certain aspects , beads having polymeric nanoparticles Example 2 
immobilized thereon may be loaded onto columns , car 
tridges , or corks to be used in line with , for example , an IV Characterization of PCL Nanoparticles — Shape , 
line , to remove any residual endotoxins in IV fluids that may Size , and Surface Charge be potentially harmful for patients . 5 
FIG . 3 depicts one exemplary filtering system 300 using The shape and size of the polymeric PCL nanoparticles 
an inline filtering device for endotoxin removal . The system prepared in Example 1 were analyzed by TEM ( Tecnai F20 ) 
300 can include a filtering device 302 having beads 304 with at 120 kV . FIG . 4 shows a TEM image of a sample of the 
polymeric nanoparticles immobilized on the outer surface of polymeric nanoparticles prepared as in Example 1 . As seen 
the beads 304 . A fluid line 306 can include a fluid 308 having 10 in the TEM image in FIG . 4 , the polymeric nanoparticles are 
endotoxin therein . The filtering device 302 can be positioned substantially uniform in size and are approximately spheri 
in the path of the fluid flow such that the fluid 308 having cal . The polymeric PCL nanoparticles prepared as in 
endotoxin flows through the filtering device 302 , allowing at Example 1 provided nanoparticles having a maximum 
least a portion of the endotoxin to bind to the polymeric dimension or maximum diameter of 398 . 3 + 95 . 13 nm in 
nanoparticles present on the surface of the beads 304 , 15 large quantities . thereby allowing a endotoxin - free or reduced endotoxin The size distribution and surface charge of the polymeric fluid 310 to flow through the line 312 exiting the filtering 
device 302 PCL nanoparticles in water were measured by dynamic light scattering ( DLS ; Malvern NanoSeries Zetasizer ZS90 ) . In an embodiment not depicted in the figures , the poly - 2 . Poly res , the poly - 20 Polymeric nanoparticle suspensions were prepared in 0 . 2 um 
meric nanoparticles may be immobilized on the inner sur syringe filtered deionized water in concentrations of 0 , 10 , face of a fluid line so that as a fluid flows , the polymeric 100 and 1000 ug / ml . The suspensions were vigorously nanoparticles can bind to endotoxin and thereby form an stirred for a minute and sonicated ( Branson ) . DLS measure endotoxin - free of reduced endotoxin fluid . ments were performed at 25° C . in disposable capillary cells 
From the foregoing , it will be seen that this invention is 25 ( Malvern ) using the backscattering detection at 90° . The size 
one well adapted to attain all the ends and objects herein distribution was obtained for 100 successive runs . The zeta 
above set forth together with other advantages which are potential was measured for 15 runs . Data was analyzed using inherent to the systems and methods . means and standard deviations of the three concentrations . 
It will be understood that certain features and subcombi - FIG . 5A shows a graph of the size distribution of the 
nations are of utility and may be employed without reference 30 polymeric nanoparticles by intensity . As seen in FIG . 5A , 
to other features and subcombinations . This is contemplated there is a single peak that is consistent with an approximate by and is within the scope of the claims . diameter of about 300 nm to about 500 nm for the polymeric 
Since many possible aspects may be made of the inven nanoparticles produced as in Example 1 , and which confirms 
tion without departing from the scope thereof , it is to be as the size distribution measured using TEM . The size distri 
understood that all matter herein set forth or shown in the bution was further confirmed by DLS with a polydispersity 
accompanying drawings is to be interpreted as illustrative index of 0 . 2 . The uniform size , as determined by both DLS 
and not in a limiting sense . and TEM , confirm that the polymeric nanoparticles did not 
aggregate after drying and dispersing in suspension when 
EXAMPLES 40 forming the nanoparticles as described in Example 1 . 
FIG . 5B shows the zeta potential distribution , which 
The concepts discussed herein will be further described in shows that the polymeric PCL nanoparticles produced as in the following examples , which do not limit the scope of the Example 1 are slightly negative at – 12 . 438 . 28 mv . 
various aspects described in the claims . Example 3 Each experiment in the below examples that included 
quantified measurements was carried out in at least three Quantification of Endotoxin Removal by the independent experiments with triplicate measurements . Data Polymeric Nanoparticles 
were summarized using means and standard deviations . 
50 A polymeric nanoparticle BODIPY - Cadaverine ( BC ) 
Example 1 based fluorescence assay was employed in order to deter 
mine the endotoxin binding efficacy . E . coli 055 : B5 endo 
Synthesis of PCL Nanoparticles toxin ( Sigma ) from E . coli bacteria was used as an 
exemplary endotoxin in this assay . 
33 First , an optimum mass ratio of BC and endotoxin was In this example , PCL nanoparticles were prepared by a determined . BC ( Invitrogen ) was dissolved in dimethyl phase separation method . A 10 mg / mL PCL ( Sigma ) solution 
in toluene was injected into a 1 % w / v polyvinyl alcohol sulfoxide ( DMSO ; Sigma ) to prepare a stock concentration of 3 . 33 mg / ml . The excitation and emission wavelengths for ( PVA ) surfactant aqueous solution using a syringe pump ( kD 
Scientific ) . The mixture was homogenized at 300 rpm . The 60 BC were 485 / 20 and 528 / 20 nm , respectively . The molar dispersion was stirred overnight at room temperature ( ~ 22° ratio of BC and endotoxin was determined from quenching 
C . ) to remove residual toluene . The polymeric nanoparticles of BC fluorescence intensity ( F . I . ) using a plate reader 
were separated from the dispersion by centrifugation at ( Biotek Synergy ) . BC of 262 . 11 ug / ml was added to differ 
4 , 600 rcf for 20 min . Particles were washed by centrifuga ent concentrations of endotoxin from 0 - 50 ug / ml in DI water 
tion three times using deionized water . The resulting nano - 65 of pH - 7 . 4 at 25° C . in a 96 - well plate ( Corning ) . 
particles were lyophilized , weighed and stored at 4° C . until FIG . 6 shows a plot of the fluorescence intensity of BC at 
further use . 262 . 11 ug / mL versus various endotoxin concentrations . In 
45 
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the absence of endotoxins , BC exhibited the highest fluo Example 4 
rescence intensity ( 1405 . 2 - 322 . 2 ) . The addition of endo 
toxin to BC sharply decreased the fluorescence intensity of Comparison of Endotoxin Removal Efficacy Per 
BC , indicating fast binding and rapid saturation of BC with Unit Surface Area 
endotoxin via quenching mechanisms . Addition of more 5 The efficiency of endotoxin removal per unit outer surface endotoxin beyond 50 ug / ml endotoxin increased the fluo area of the polymeric nanoparticles was calculated , and 
rescence intensity of BC indicating that there was an opti compared with that reported for a commercially available 
mum BC : endotoxin working ratio of 5 . 24 w : W ratio . 50 membrane ( Pall ) . The calculations were done using Eq . 2 as 
ug / ml endotoxin were used to evaluate the binding efficiency described above , where , W is the concentration of nanopar 
of the polymeric nanoparticles . ticles in g / ml , p is the density of PCL polymer in g / ml , and 
Using this BC : endotoxin working ratio , the quantification o is the diameter of the PCL nanoparticles in um . In the 
of endotoxin removal via the polymeric nanoparticles was present example , the number of polymeric PCL nanopar 
determined . As mentioned above , the binding of endotoxin ticles / ml was calculated for 50 ug / ml , which showed the 
was determined using a BC fluorescence displacement highest endotoxin removal efficacy with a p of 1 . 146 g / ml at 
assay . In this displacement assay , 50 ug / ml endotoxin was 15 25° C . and a particle diameter of q = 0 . 398 um . Then the total 
mixed with 262 . 11 ug / ml BC in 0 . 6 ml deionized water number of polymeric PCL nanoparticles and the total outer 
( pH - 7 . 4 ) in a 1 . 5 ml centrifuge tube ( Corning ) . Serial surface area of polymeric PCL nanoparticles in the final 
dilutions of polymeric PCL nanoparticles ( made as above ) of volume of 0 . 6 ml were calculated . These values appear in 
0 , 0 . 1 , 1 , 2 , 5 , 10 , 15 , 20 , 25 , 30 , 40 and 50 ug / ml were added Table 1 , below . 
TABLE 1 





Diameter of a 
PCL PCL 
nanoparticle nanoparticle , PCL Surface area / Endotoxin 
density , p nanoparticles / ml nanoparticle concentration 
( g / ml ) ( um ) by Eq . ( 2 ) ( cm ~ / ml ) ( EU / ml ) 
1 . 146 0 . 3983 2 . 1 x 108 0 . 335 5 x 105 
( g / ml ) 
Endotoxin 
removal 
( EU / cm² 
nanoparticle ) 
1 . 49 x 106 5 x 10 - 5 
to the tube to measure endotoxin - binding efficiency . As Finally , the number of EU per unit area of nanoparticles 
endotoxins became bound to the surfaces of the polymeric was calculated by equation 3 described above . The total 
PCL nanoparticles , the endotoxins released BC causing an endotoxin removal per unit outer surface area of polymeric 
increase in BC fluorescence intensity . The change in fluo - 35 nanoparticle was 1 . 49x106 EU / cm2 . 
rescence intensity of BC was determined using the plate The removal efficacy per unit outer surface area of the 
reader ( Biotek ) . The background fluorescence intensities of polymeric nanoparticles ( 1 . 49x106 EU / cm2 ) is 6 . 7 fold more 
BC and polymeric nanoparticle control , BC and endotoxin efficient than a commercially available hydrophobic charged 
control , BC alone were subtracted to avoid any interfer - microporous membrane . A membrane that has a porous 
ences . The % endotoxin removal efficiency of the various hydrophobic polyether sulfone matrix , and polyamines 
concentrations of polymeric PCL nanoparticles were deter - within the matrix ( Pall Corporation ) has been shown to bind 
mined by Eq . 1 listed above . FIG . 7 shows a plot of the up to 2 . 23x10 % EU / cm² . Porous silica gel matrix with silica 
percent endotoxin removal efficiency against the various particles showed endotoxin removal capacity of 1 . 2x107 
polymeric PCL concentrations . 45 EU / g , while PCL nanoparticles removed almost 655 times 
When the polymeric nanoparticles were added to the more ( 7 . 9x10° EU / g ) endotoxin with an initial concentration 
aqueous mixture of BC and endotoxin ( 5 . 24 w : w ratio ) , the of 0 . 5x10° EU / ml . Cellulose beads in an ETClean chromato 
polymeric nanoparticles competitively bound to endotoxin graphic column have been shown to provide a removal 
displacing its binding with BC . As a result and as can be seen capacity of 4 . 8x106 EU / ml . These results suggest that a 
in FIG . 7 . the fluorescence intensity of BC increased from its 50 support based system could be utilized , such as embedding 
quenched state in equilibrium with endotoxin with the the polymeric nanoparticles or affixing the polymeric nano 
endotoxin binding to the polymeric nanoparticles . As bind particles to a support member as discussed above , to further 
ing increased between endotoxin and the polymeric nano enhance the endotoxin removal capacity of the polymeric 
particles , the % increase in fluorescence intensity of BC also nanoparticles . 
increased , indicating a proportional relationship between the Example 5 two . The % increase in fluorescence intensity of BC was 
used to calculate endotoxin - binding removal efficiencies of Endotoxin - PCL Nanoparticle Binding as Imaged by polymeric PCL nanoparticles by Eq . 1 . PCL nanoparticles TEM and Measured by Surface Charges 
effectively removed up to 78 . 78 28 . 84 % endotoxin . 60 
The binding curve of FIG . 7 showed a two - step mecha - TEM was used for high - magnification visualization of 
nism reflecting the formation of initial endotoxin hitchhik - endotoxin binding on polymeric PCL nanoparticles . 50 
ing at low concentrations to multiple endotoxin hitchhiking ug / ml endotoxin was incubated with 50 ug / ml polymeric 
to a single nanoparticle as the concentration reaches to PCL nanoparticles produced as in Example 1 in a 1 . 5 ml 
saturation . Indeed , as described in Example 5 below , TEM 65 centrifuge tube for 10 min . 10 ul of the sample was put on 
images ( in FIGS . 8A and 8B ) show multiple endotoxin top of a pre - wetted copper - carbon TEM grid ( Tedpella ) , 
molecules binding to the same polymeric nanoparticle . air - dried for an hour and further dried in a desiccator until 
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being imaged by a TEM ( Tecnai F20 ) at 120 kV . FIGS . 8A TABLE 3 
and 8B are two TEM images showing how more than one 
endotoxin molecule binds a single polymeric PCL nanopar Cost and Capacity Comparison of PCL Nanoparticles and a Commercial Resin ticle . 
Endotoxin Endotoxin binding was also confirmed by changes in Removal 
surface charges of endotoxin solution alone and endotoxin Method Price of Solution ( ng / ml )
PCL mixture . Samples were loaded in pre - rinsed folded 
capillary cells ( Malvern ) for surface charge measurements Polycaprolactone Nanoparticles $ 0 . 972 / ml of solution 2 . 50E + 08 Thermo Scientific Endotoxin $ 27 . 20 / ml of solution 2 . 00E + 05 
using a Nanoseries Zetasizer ( Malvern ) . A minimum of three 10 Removal Resin 
individual samples was measured . FIG . 9A shows the zeta 
potential distribution of pure endotoxin , which exhibits a As can be seen in Table 3 , the PCL nanoparticles can highly negative surface charge of - 27 . 76 . 1 mV that was remove at least 103 more endotoxin per mL of nanoparticles compensated by the net negative charge of PCL nanopar 
ticles . After being hitchhiked on ( or bound to ) the nanopar - 15 compared to a mL of commercially available endotoxin 
removal resin . ticles , the net surface charge of endotoxins increased to 
- 14 . 7 + 3 . 63 mV ( as seen in FIG . 9B ) , indicating a charge 
overcompensation by polymeric PCL nanoparticle binding . What is claimed is : 1 . An endotoxin removal system , comprising : 
20 a plurality of polymeric nanoparticles , each polymeric Example 6 nanoparticle of the plurality of polymeric nanoparticles 
having a maximum dimension between 300 nm and 
Comparison of Endotoxin Binding to Nanoparticles 500 nm ; and 
and Polymers a support member associated with the plurality of poly 
meric nanoparticles , wherein , when an aqueous solu 
tion comprising endotoxin molecules is exposed to the 
A fluorescence - based assay was utilized to compare the endotoxin removal system , the support member and the 
endotoxin binding ability of PCL nanoparticles to various plurality of polymeric nanoparticles are cooperatively 
polymers . As can be seen in FIG . 10A , the fluorescence configured to separate at least a portion of the endo intensity of BODIPY decreases with increasing amounts of 30 toxin molecules from the aqueous solution , and 
endotoxin ( e . g . , E . coli 055 : B5 endotoxin ) . It is believed that wherein each polymeric nanoparticle of the plurality of 
the endotoxin binds to BODIPY and quenches the BODIPY polymeric nanoparticles has an endotoxin removal 
fluorescence signal . When the polymer or nanoparticles bind capacity of at least 1x10° endotoxin units per gram of 
to the endotoxin , the endotoxin is no longer free to bind to polymeric nanoparticle ( EU / g ) . 
BODIPY and quench the BODIPY fluorescence signal , thus 35 2 . The endotoxin removal system of claim 1 , wherein each 
the level of the BODIPY fluorescence signal correlates with polymeric nanoparticle of the plurality of polymeric nano 
the amount of polymer ( or nanoparticle ) binding to endo particles has an endotoxin removal efficacy of at least 1x100 
toxin ( in the presence of BODIPY ) . FIGS . 10B - 10E depicts endotoxin units per cm of polymeric nanoparticle surface 
the fluorescence intensity of BODIPY in the presence of area ( EU / cm2 ) . 
varying concentration of various polymers ( FIGS . 10B , 10C , 40 3 . The endotoxin removal system of claim 1 , wherein each 
and 10E ) or in the presence of varying concentrations of polymeric nanoparticle of the plurality of polymeric nano 
PCL nanoparticles ( FIG . 10D ) . Further , Table 2 below particles comprises a polyester . 
shows the maximum percent removal of endotoxin for the 4 . The endotoxin removal system of claim 3 , wherein the 
various polymers of nanoparticles , which was calculated polyester comprises Poly ( e - caprolactone ) ( PCL ) . 
based on the data in FIGS . 10A - 10E . 45 5 . The endotoxin removal system of claim 1 , wherein the 
support member comprises a film . 
TABLE 2 6 . The endotoxin removal system of claim 5 , wherein the 
film comprises cellulose . Comparison of Endotoxin Removal 7 . The endotoxin removal system of claim 1 , wherein the 
Polymer or Nanoparticle Maximum Percent Removal of Endotoxin 50 support member comprises a plurality of beads , the plurality 
of beads comprising silica , silicon , cellulose , or a mixture 1 , 4 C - 1 , 4 Bis Polymer 72 % 
EGDE - 3 , 3 ' Polymer thereof . 77 % 
PCL nanoparticles 47 % 8 . A method for removing endotoxins from an aqueous 
Polyethyleneimine Polymer 73 % solution , the method comprising : 
exposing an aqueous solution comprising endotoxin mol 
ecules to polymeric nanoparticles so that at least a As can be seen in FIGS . 10B - 10E and Table 2 , the portion of the endotoxin molecules bind to an exterior polymers show endotoxin binding at lower polymer con surface of one or more of the polymeric nanoparticles 
centrations ( compared to the PCL nanoparticle concentra to form endotoxin - bound polymeric nanoparticles , tions for endotoxin binding ) . However , as can be seen in 60 wherein each of the polymeric nanoparticles has a 
FIG . 10D , the PCL nanoparticles can remove a high con maximum dimension of about 300 nm to about 500 nm , 
centration of endotoxin . and wherein each of the polymeric nanoparticles have 
Material cost analysis shows that polymeric nanopar an endotoxin removal capacity of at least 1x10° endo 
ticles , e . g . , PCL nanoparticles , offer a significantly greater toxin units per gram of polymeric nanoparticle ( EU / g ) ; 
cost effectiveness . Table 3 shows a comparison of the costs 65 and 
associated with endotoxin removal by PCL nanoparticles removing at least a portion of the aqueous solution from 
versus a commercially available resin . the endotoxin - bound polymeric nanoparticles . 
55 
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9 . The method of claim 8 , wherein the polymeric nano 
particles comprise a polyester . 
10 . The method of claim 9 , wherein the polyester com 
prises Poly ( e - caprolactone ) ( PCL ) , polylactic acid ( PLA ) , 
Poly ( lactic - co - glycolic acid ( PLGA ) , hyaluronic acid ( HA ) , 5 
poly ( acrylic acid ) ( PAA ) , poloxamers , polyethylene oxide 
( PEO ) , polyethylene glycol ( PEG ) , polyflutamic acid , or a 
mixture thereof . 
11 . The method of claim 8 , wherein the polymeric nano 
particles are associated with a support member , wherein the 10 
support member comprises one of a film or a plurality of 
beads . 
12 . The method of claim 11 , wherein the support member 
comprises the plurality of beads , wherein the plurality of 
beads comprise at least one of silica , silicon , or cellulose . 15 
13 . The method of claim 8 , wherein each of the polymeric 
nanoparticles has an endotoxin removal efficacy of at least 
1x10 “ endotoxin units per cm² of nanoparticle surface area ( EU / cm² ) . 
14 . The method of claim 8 , wherein the removing at least 20 
a portion of the aqueous solution from the endotoxin - bound 
polymeric nanoparticles comprises flowing the at least a 
portion of the aqueous solution past the polymeric nanopar 
ticles when the polymeric nanoparticles are at least partly 
immobilized by association with at least one of a film , a 25 
membrane , or beads . 
15 . A method for removing endotoxins from an aqueous 
solution , the method comprising : 
exposing an aqueous solution comprising endotoxin mol 
ecules to polymeric nanoparticles so that at least a 
portion of the endotoxin molecules bind to an outer 
surface of one or more of the polymeric nanoparticles 
to form endotoxin - bound polymeric nanoparticles , 
wherein at least the outer surface of each of the 
polymeric nanoparticles comprises Poly ( e - caprolac 
tone ) ( PCL ) , wherein each of the polymeric nanopar 
ticles has a maximum dimension of about 300 nm to 
about 500 nm , and wherein the polymeric nanoparticles 
have an endotoxin removal capacity of at least about 1x10° endotoxin units per gram of polymeric nanopar 
ticle ( EU / g ) and an endotoxin removal efficacy of at 
least 1x10° endotoxin units per cm² of nanoparticle 
surface area ( EU / cm² ) . 
16 . The method of claim 15 , wherein the endotoxin 
molecules comprise an endotoxin from one or more Gram 
negative bacterial species . 
17 . The method of claim 16 , wherein the one or more 
Gram negative bacterial species comprises E . coli . 
18 . The method of claim 15 , wherein the polymeric 
nanoparticles are embedded in a film . 
19 . The method of claim 15 , wherein the polymeric 
nanoparticles are coupled to beads . 
20 . The method of claim 15 , wherein at least a portion of 
the polymeric nanoparticles are spherical . 
* * * * 
